Literature DB >> 10462239

Differentiation of convalescent animals from those vaccinated against foot-and-mouth disease by a peptide ELISA.

F Shen1, P D Chen, A M Walfield, J Ye, J House, F Brown, C Y Wang.   

Abstract

We have identified continuous antigenic determinants within the amino acid sequences of the conserved nonstructural region containing proteins 2C and 3ABC of foot-and-mouth disease virus which can distinguish between the sera from vaccinated and infected animals. An ELISA based on a 3B peptide gave a positive reaction with sera from cattle, pigs, sheep and guinea pigs infected with all seven serotypes of the virus, but not with sera from vaccinated animals. In experiments with cattle and pigs to determine the duration of the antibody response, positive reactions were obtained as late as one year after infection. The advantages of using peptides from the nonstructural viral proteins instead of recombinant proteins for differentiating vaccinees from infected animals include their exquisite specificity, nonreactivity with antibodies against host cell-derived proteins (e.g. E. coli and insect cell proteins), and their ease of preparation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10462239     DOI: 10.1016/s0264-410x(99)00148-6

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  17 in total

1.  Foot and mouth disease: why not vaccinate?

Authors:  J Beale
Journal:  J R Soc Med       Date:  2001-06       Impact factor: 5.344

Review 2.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

Review 3.  An overview on ELISA techniques for FMD.

Authors:  Li-na Ma; Jie Zhang; Hao-tai Chen; Jian-hua Zhou; Yao-zhong Ding; Yong-sheng Liu
Journal:  Virol J       Date:  2011-09-04       Impact factor: 4.099

4.  Pan-Serotype Diagnostic for Foot-and-Mouth Disease Using the Consensus Antigen of Nonstructural Protein 3B.

Authors:  Alyssa K Van Dreumel; Wojtek P Michalski; Leanne M McNabb; Brian J Shiell; Nagendrakumar B Singanallur; Grantley R Peck
Journal:  J Clin Microbiol       Date:  2015-03-18       Impact factor: 5.948

5.  Expression of Foot-and-Mouth Disease Virus Non-Structural Protein, 3D in Insect Cells and its Application in Detection of Anti-FMDV Antibodies.

Authors:  Rakesh Kumar; M Hosamani; B P Sreenivasa; Anil Kotyal; R Venkataramanan
Journal:  Indian J Virol       Date:  2012-09-06

6.  Differentiation of foot-and-mouth disease virus-infected from vaccinated pigs by enzyme-linked immunosorbent assay using nonstructural protein 3AB as the antigen and application to an eradication program.

Authors:  Wen-Bin Chung; Karl Johan Sorensen; Pei-Chih Liao; Pin-Cheng Yang; Ming-Hwa Jong
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

7.  Identification of foot-and-mouth disease virus-specific linear B-cell epitopes to differentiate between infected and vaccinated cattle.

Authors:  Bettina-Judith Höhlich; Karl-Heinz Wiesmüller; Tobias Schlapp; Bernd Haas; Eberhard Pfaff; Armin Saalmüller
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

8.  Comparison of two 3ABC enzyme-linked immunosorbent assays for diagnosis of multiple-serotype foot-and-mouth disease in a cattle population in an area of endemicity.

Authors:  B M de C Bronsvoort; K J Sørensen; J Anderson; A Corteyn; V N Tanya; R P Kitching; K L Morgan
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

9.  A safe foot-and-mouth disease vaccine platform with two negative markers for differentiating infected from vaccinated animals.

Authors:  Sabena Uddowla; Jason Hollister; Juan M Pacheco; Luis L Rodriguez; Elizabeth Rieder
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

10.  Use of a standardized bovine serum panel to evaluate a multiplexed nonstructural protein antibody assay for serological surveillance of foot-and-mouth disease.

Authors:  Julie Perkins; Satya Parida; Alfonso Clavijo
Journal:  Clin Vaccine Immunol       Date:  2007-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.